Tezacaftor-ivacaftor for the treatment of cystic fibrosis: what’s next?

J. Davies (London, United Kingdom)

Source: International Congress 2018 – Therapeutic breakthroughs Year in Review
Session: Therapeutic breakthroughs Year in Review
Session type: Year in review
Number: 1903

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Davies (London, United Kingdom). Tezacaftor-ivacaftor for the treatment of cystic fibrosis: what’s next?. International Congress 2018 – Therapeutic breakthroughs Year in Review

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: